EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2018 Update

Summary

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central laboratories. Its POC range includes hemoglobin analyzers, glucose analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its Central Laboratory range includes various clinical reagents and centrifuges. Its products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. EKF Diagnostics offers its products across the world through its subsidiaries and distributors. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EKF Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

2
List of Tables 4
List of Figures 4
EKF Diagnostics Holdings Plc Company Overview 6
EKF Diagnostics Holdings Plc Company Snapshot 6
EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview 6
EKF Diagnostics Holdings Plc Pipeline Analysis Overview 9
Business Description 9
EKF Diagnostics Holdings Plc - Key Facts 9
EKF Diagnostics Holdings Plc - Major Products and Services 10
EKF Diagnostics Holdings Plc Pipeline Products by Development Stage 12
EKF Diagnostics Holdings Plc Pipeline Products Overview 14
Altair 240 14
Altair 240 Product Overview 14
BIOSEN HbA1c Instrument 15
BIOSEN HbA1c Instrument Product Overview 15
DiaSpect 16
DiaSpect Product Overview 16
Point-Of-Care Test - Coagulation 17
Point-Of-Care Test - Coagulation Product Overview 17
Point-Of-Care Test - Vitamin D Test 18
Point-Of-Care Test - Vitamin D Test Product Overview 18
PointMan AKT DNA Enrichment Kit 19
PointMan AKT DNA Enrichment Kit Product Overview 19
PointMan Assay - Breast Cancer 20
PointMan Assay - Breast Cancer Product Overview 20
PointMan Assay - Lung Cancer 21
PointMan Assay - Lung Cancer Product Overview 21
PointMan Assay - Skin Cancer 22
PointMan Assay - Skin Cancer Product Overview 22
PointMan C-Met DNA Enrichment Kit 23
PointMan C-Met DNA Enrichment Kit Product Overview 23
PointMan FGFR2 DNA Enrichment Kit 24
PointMan FGFR2 DNA Enrichment Kit Product Overview 24
PointMan FGFR4 DNA Enrichment Kit 25
PointMan FGFR4 DNA Enrichment Kit Product Overview 25
PointMan PI3K DNA Enrichment Kit 26
PointMan PI3K DNA Enrichment Kit Product Overview 26
PointMan ROS DNA Enrichment Kit 27
PointMan ROS DNA Enrichment Kit Product Overview 27
Quo-Lab - C-Reactive Protein 28
Quo-Lab - C-Reactive Protein Product Overview 28
RenaStat 29
RenaStat Product Overview 29
SensPoint 30
SensPoint Product Overview 30
-Hydroxybutyrate LiquiColor Reagent 31
-Hydroxybutyrate LiquiColor Reagent Product Overview 31
Xtract Liquid Phase Extraction Device 32
Xtract Liquid Phase Extraction Device Product Overview 32
EKF Diagnostics Holdings Plc - Key Competitors 33
EKF Diagnostics Holdings Plc - Key Employees 34
EKF Diagnostics Holdings Plc - Key Employee Biographies 35
EKF Diagnostics Holdings Plc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 38
EKF Diagnostics Holdings Plc, Recent Developments 38
Apr 30, 2018: EKF secures FDA clearance for DiaSpect Tm POC hemoglobin analyzer 38
Apr 26, 2018: EKF Diagnostics Holdings Announce Shelf-life Extension for DiaSpect HBT Controls 38
Apr 09, 2018: EKF Diagnostics Announce US FDA clearance for Diaspect Tm Hemoglobin Analyzer 38
Apr 09, 2018: Clinical Laserthermia Systems Introduces MRI-Guided Laser Ablation System For Minimally-Invasive Treatment Of Soft Tissue 39
Apr 09, 2018: EKF Diagnostics: US FDA approval For DiaSpect 39
Mar 14, 2018: EKF Diagnostics Holdings: 2017 Final results 40
Nov 21, 2017: EKF hemoglobin analyzer Hemo Control experience in Peru 43
Nov 14, 2017: EKF introduces mobile data management solution for the DiaSpect Tm POC hemoglobin analyzer 43
Nov 02, 2017: EKF Procalcitonin Assay FDA cleared and validated for Beckman AU chemistry analyzers 44
Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 45
Appendix 46
Methodology 46
About GlobalData 48
Contact Us 48
Disclaimer 49

List Of Tables

List of Tables
EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview 6
EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type 7
EKF Diagnostics Holdings Plc Pipeline Products by Indication 8
EKF Diagnostics Holdings Plc, Key Facts 9
EKF Diagnostics Holdings Plc, Major Products and Services 10
EKF Diagnostics Holdings Plc Number of Pipeline Products by Development Stage 12
EKF Diagnostics Holdings Plc Pipeline Products Summary by Development Stage 13
Altair 240 - Product Status 14
Altair 240 - Product Description 14
BIOSEN HbA1c Instrument - Product Status 15
BIOSEN HbA1c Instrument - Product Description 15
DiaSpect - Product Status 16
DiaSpect - Product Description 16
Point-Of-Care Test - Coagulation - Product Status 17
Point-Of-Care Test - Coagulation - Product Description 17
Point-Of-Care Test - Vitamin D Test - Product Status 18
Point-Of-Care Test - Vitamin D Test - Product Description 18
PointMan AKT DNA Enrichment Kit - Product Status 19
PointMan AKT DNA Enrichment Kit - Product Description 19
PointMan Assay - Breast Cancer - Product Status 20
PointMan Assay - Breast Cancer - Product Description 20
PointMan Assay - Lung Cancer - Product Status 21
PointMan Assay - Lung Cancer - Product Description 21
PointMan Assay - Skin Cancer - Product Status 22
PointMan Assay - Skin Cancer - Product Description 22
PointMan C-Met DNA Enrichment Kit - Product Status 23
PointMan C-Met DNA Enrichment Kit - Product Description 23
PointMan FGFR2 DNA Enrichment Kit - Product Status 24
PointMan FGFR2 DNA Enrichment Kit - Product Description 24
PointMan FGFR4 DNA Enrichment Kit - Product Status 25
PointMan FGFR4 DNA Enrichment Kit - Product Description 25
PointMan PI3K DNA Enrichment Kit - Product Status 26
PointMan PI3K DNA Enrichment Kit - Product Description 26
PointMan ROS DNA Enrichment Kit - Product Status 27
PointMan ROS DNA Enrichment Kit - Product Description 27
Quo-Lab - C-Reactive Protein - Product Status 28
Quo-Lab - C-Reactive Protein - Product Description 28
RenaStat - Product Status 29
RenaStat - Product Description 29
SensPoint - Product Status 30
SensPoint - Product Description 30
-Hydroxybutyrate LiquiColor Reagent - Product Status 31
-Hydroxybutyrate LiquiColor Reagent - Product Description 31
Xtract Liquid Phase Extraction Device - Product Status 32
Xtract Liquid Phase Extraction Device - Product Description 32
EKF Diagnostics Holdings Plc, Key Employees 34
EKF Diagnostics Holdings Plc, Key Employee Biographies 35
EKF Diagnostics Holdings Plc, Other Locations 36
EKF Diagnostics Holdings Plc, Subsidiaries 36
Glossary 47

List Of Figures

List of Figures
EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type 7
EKF Diagnostics Holdings Plc Pipeline Products by Development Stage 12

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2018 Update

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central

USD 750 View Report

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

EKF DIAGNOSTICS HOLDINGS PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

EKF DIAGNOSTICS HOLDINGS PLC Company Profile is a detailed strategic and analytical report on EKF DIAGNOSTICS HOLDINGS PLC. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available